Gurney H - Search Results

1

Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio.

Lee CI, Low SK, Maldonado R, Fox P, Balakrishnar B, Coulter S, de Bruijn P, Koolen SLW, Gao B, Lynch J, Zdenkowski N, Hui R, Liddle C, Mathijssen RHJ, Wilcken N, Wong M, Gurney H. Lee CI, et al. Among authors: gurney h. Breast. 2020 Dec;54:229-234. doi: 10.1016/j.breast.2020.10.008. Epub 2020 Oct 21. Breast. 2020. PMID: 33161337 Free PMC article.

2

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy.

Wong M, Balleine RL, Collins M, Liddle C, Clarke CL, Gurney H. Wong M, et al. Among authors: gurney h. Clin Pharmacol Ther. 2004 Jun;75(6):529-38. doi: 10.1016/j.clpt.2004.02.005. Clin Pharmacol Ther. 2004. PMID: 15179407

3

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.

Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, Clarke CL, Balleine RL, Gurney H. Wong M, et al. Among authors: gurney h. Clin Pharmacol Ther. 2005 Jan;77(1):33-42. doi: 10.1016/j.clpt.2004.09.002. Clin Pharmacol Ther. 2005. PMID: 15637529

4

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.

Wong M, Balleine RL, Blair EY, McLachlan AJ, Ackland SP, Garg MB, Evans S, Farlow D, Collins M, Rivory LP, Hoskins JM, Mann GJ, Clarke CL, Gurney H. Wong M, et al. Among authors: gurney h. J Clin Oncol. 2006 Jun 1;24(16):2448-55. doi: 10.1200/JCO.2005.02.1295. Epub 2006 May 1. J Clin Oncol. 2006. PMID: 16651648

5

Dose calculation of anticancer drugs.

Gao B, Klumpen HJ, Gurney H. Gao B, et al. Among authors: gurney h. Expert Opin Drug Metab Toxicol. 2008 Oct;4(10):1307-19. doi: 10.1517/17425255.4.10.1307. Expert Opin Drug Metab Toxicol. 2008. PMID: 18798700 Review.

6

Irinogenetics: how many stars are there in the sky?

Mathijssen RH, Gurney H. Mathijssen RH, et al. Among authors: gurney h. J Clin Oncol. 2009 Jun 1;27(16):2578-9. doi: 10.1200/JCO.2008.21.2480. Epub 2009 Apr 6. J Clin Oncol. 2009. PMID: 19349537 No abstract available.

7

Moving towards dose individualization of tyrosine kinase inhibitors.

Klümpen HJ, Samer CF, Mathijssen RH, Schellens JH, Gurney H. Klümpen HJ, et al. Among authors: gurney h. Cancer Treat Rev. 2011 Jun;37(4):251-60. doi: 10.1016/j.ctrv.2010.08.006. Epub 2010 Sep 15. Cancer Treat Rev. 2011. PMID: 20833478 Review.

8

Evidence for therapeutic drug monitoring of targeted anticancer therapies.

Gao B, Yeap S, Clements A, Balakrishnar B, Wong M, Gurney H. Gao B, et al. Among authors: gurney h. J Clin Oncol. 2012 Nov 10;30(32):4017-25. doi: 10.1200/JCO.2012.43.5362. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927532 Review.

9

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2.

Zhou F, Zheng J, Zhu L, Jodal A, Cui PH, Wong M, Gurney H, Church WB, Murray M. Zhou F, et al. Among authors: gurney h. AAPS J. 2013 Oct;15(4):1099-108. doi: 10.1208/s12248-013-9515-1. Epub 2013 Aug 6. AAPS J. 2013. PMID: 23918469 Free PMC article.

10

Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study.

Kloth JS, Klümpen HJ, Yu H, Eechoute K, Samer CF, Kam BL, Huitema AD, Daali Y, Zwinderman AH, Balakrishnar B, Bennink RJ, Wong M, Schellens JH, Mathijssen RH, Gurney H. Kloth JS, et al. Among authors: gurney h. Clin Pharmacokinet. 2014 Mar;53(3):261-269. doi: 10.1007/s40262-013-0111-4. Clin Pharmacokinet. 2014. PMID: 24234588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page